In this month of Pink October dedicated to breast cancer awareness, an association deplores unequal access to screening for this disease depending on the density of patients’ breasts. According to a doctor, cancerous masses are sometimes unreadable by mammography for women with “dense breasts”.
“Whether soft, bumpy or firm, only mammography can determine breast density” expresses the clinical professor at the University of British Columbia and member of Dense Breast Canada Paula gordon.
According to her, breast density, classified into four size categories, can have a real impact on the detection of cancer.
On any type of chest X-ray, such as a mammogram, breast tissue appears white and fat appears dark gray.
“The problem is that the masses, whether cancerous or not, also appear white on the mammogram,” she explains.
Thus, it appears more challenging, depending to Paula Gordon, to distinguish cancer cells that blend into the white shades of the tissue during this type of examination.
It’s like trying to spot a snowball in a snowstorm.
Advocates Push for Broader Access to Advanced Breast Cancer Screening
Table of Contents
A Quebec breast cancer advocacy group is calling for expanded access to more advanced screening methods,arguing that current guidelines might potentially be missing cancers in women who aren’t considered high-risk. Dr. Jennie Dale, director of the Breast Cancer Action Quebec association, believes that relying solely on mammograms, MRI, or ultrasound for women at very high risk (like BRCA gene carriers) leaves a significant gap in detection.
The Limitations of Current Screening
Current screening practices primarily focus on women in categories A, B, C, and D, based on their risk factors. Category D represents those at the highest risk. However, Dr. Dale points out that the majority of cancers occur in category C – women who have a moderate risk but aren’t automatically offered additional screening. this means some cancers may go undetected untill they reach a more advanced stage.
“The majority of these cancers occur in category C. This is why they must also have access to additional screening,” she states.She argues that offering more complete screening to this group could lead to earlier detection and improved outcomes.
Unequal Access to Advanced Technologies
A key concern raised by Dr. Dale is the inequitable access to advanced screening technologies like MRI and specialized ultrasound. Currently, these options are largely confined to the private sector, creating a disparity in care. She believes the public health system should offer these tools to all individuals with breasts who could benefit, not just those deemed at the highest risk.
“It’s unfair that these options are not offered to all people with breasts by the public health system,” she explains. This lack of access perhaps delays diagnosis and treatment for women who might otherwise be identified with cancer at an earlier, more treatable stage.
Key Takeaways
- Current breast cancer screening guidelines may not adequately detect cancers in women with moderate risk (Category C).
- Advanced screening methods like MRI and specialized ultrasound are primarily available through the private healthcare system.
- Advocates are calling for broader access to these technologies within the public health system to ensure equitable care.
- Early detection is crucial for improving breast cancer outcomes.
Publication Date: 2025/10/11 00:42:34
Looking ahead, the Breast Cancer Action Quebec association plans to continue advocating for policy changes that prioritize equitable access to comprehensive breast cancer screening. They hope to engage with health officials and policymakers to demonstrate the potential benefits of expanding screening criteria and integrating advanced technologies into the public health system, ultimately saving lives and improving the quality of care for all.